When a medication causes unexpected harm — whether from a dangerous side effect, a manufacturing defect, or inadequate labeling — the legal path forward looks different from a typical accident claim. A drug injury attorney is a personal injury lawyer who handles cases where pharmaceutical products have caused physical harm. Understanding how these cases work, what factors shape them, and why they're legally complex can help you make sense of what you're facing.
Drug injury claims fall under the broader category of product liability law. Unlike a car accident where fault centers on a driver's behavior, pharmaceutical injury cases examine whether a drug itself — or how it was made, marketed, or labeled — caused harm.
Three legal theories typically apply:
Identifying which theory applies requires examining clinical trial data, FDA communications, prescribing records, and medical literature — which is why these cases are rarely straightforward.
Drug injury cases often involve multiple parties:
| Potentially Liable Party | Possible Basis |
|---|---|
| Pharmaceutical manufacturer | Design defect, failure to warn, marketing decisions |
| Generic drug manufacturer | Manufacturing defect (design liability limited under federal law) |
| Pharmacy or distributor | Dispensing errors, storage failures |
| Prescribing physician | Off-label prescribing without adequate disclosure |
| Hospital or healthcare system | Formulary decisions, administration errors |
Federal law — particularly as interpreted by the U.S. Supreme Court — limits what claims can be brought against generic drug manufacturers in certain contexts. This is one reason why the specific drug and its manufacturer matter significantly to how a case can proceed.
Attorneys who take these cases typically:
Causation is the central challenge in drug injury cases. It's not enough to show that someone took a drug and experienced a health problem — the claim must demonstrate that the drug was a substantial cause of that specific injury, which often requires expert testimony and scientific evidence.
Drug injury claims can proceed in several ways, depending on how widespread the harm is:
Individual lawsuits are filed by a single plaintiff in state or federal court. These are common when injuries are severe and clearly linked to the drug.
Mass torts involve many individual plaintiffs with similar claims consolidated for pretrial proceedings, often in federal court through a process called multidistrict litigation (MDL). Each plaintiff still has an individual case — this isn't the same as a class action.
Class actions treat the plaintiffs as a group, with a shared settlement. These are more common when economic harm is widespread but individual damages are modest.
Whether an existing MDL or class action is open for a particular drug affects whether a new individual claim can be filed separately or must be coordinated with existing litigation.
Most drug injury attorneys work on a contingency fee basis, meaning they receive a percentage of any recovery — typically ranging from 25% to 40%, though this varies by firm, case complexity, and jurisdiction. If there's no recovery, the client generally pays no attorney fee.
However, litigation costs — expert witness fees, court filing fees, medical record retrieval — are separate from attorney fees and can be substantial in pharmaceutical cases. Some firms advance these costs and deduct them from a recovery. Others may require reimbursement regardless of outcome. How costs are handled should be clarified before any agreement is signed.
Every state sets a statute of limitations — a deadline to file a lawsuit. For drug injury claims, these typically range from one to four years, but the starting point varies. Most states apply the discovery rule: the clock begins when a person knew or reasonably should have known that their injury was caused by the drug, not necessarily when they first took it.
This distinction matters because drug-related injuries are sometimes not connected to a medication until months or years after treatment ends.
Some states also have statutes of repose that set an absolute outer deadline regardless of when harm was discovered. Federal law may preempt certain state claims in ways that affect what can be filed at all.
No two drug injury cases produce the same result. Factors that affect how these cases resolve include:
Some drug injury cases settle early — particularly when a manufacturer has already established a litigation fund. Others go through years of discovery, expert battles, and trial. Many fall somewhere between.
The legal framework for drug injury claims is built on variables: which drug, which manufacturer, which state, which legal theory, which type of proceeding, and what the science shows. Federal preemption rules, state tort law, existing litigation structures, and the specific facts of how a person was harmed all interact in ways that produce very different outcomes for people who might appear to have similar situations on the surface.
